Are  	Are  	 VBP	O
soluble  	soluble  	 JJ	O
IL-2  	IL-2  	 CD	B-NP
receptor  	receptor  	 NN	I-NP
and  	and  	 CC	O
IL-12p40  	IL-12p40  	 CD	B-NP
levels  	levels  	 NNS	I-NP
useful  	useful  	 JJ	O
markers  	markers  	 NN	O
for  	for  	 IN	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
tuberculous  	tuberculous  	 JJ	B-NP
pleurisy 	pleurisy 	 NN	I-NP
?  	?  	 .	O
The  	The  	 DT	O
differential  	differential  	 JJ	B-NP
diagnostic  	diagnostic  	 JJ	I-NP
utilities  	utilities  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
soluble  	soluble  	 JJ	O
interleukin  	interleukin  	 NNS	B-NP
( 	( 	 -LRB-	O
IL 	IL 	 NNP	B-NP
) 	) 	 -RRB-	O
-12p40  	-12p40  	 NNP	O
and  	and  	 CC	O
the  	the  	 DT	O
IL-2  	IL-2  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
in  	in  	 IN	O
sera  	sera  	 NN	B-NP
and  	and  	 CC	O
pleural  	pleural  	 JJ	B-NP
effusions  	effusions  	 NN	I-NP
were  	were  	 VBD	O
evaluated  	evaluated  	 VBN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
exudative  	exudative  	 JJ	B-NP
pleural  	pleural  	 JJ	I-NP
effusions 	effusions 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
enrolled  	enrolled  	 VBD	O
a  	a  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
120  	120  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
exudative  	exudative  	 JJ	B-NP
pleural  	pleural  	 JJ	I-NP
effusions 	effusions 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
clinical 	clinical 	 JJ	O
,  	,  	 ,	O
radiological 	radiological 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
histopathological  	histopathological  	 JJ	B-NP
diagnoses  	diagnoses  	 NN	I-NP
were  	were  	 VBD	O
tuberculous  	tuberculous  	 JJ	B-NP
pleurisy  	pleurisy  	 NN	I-NP
in  	in  	 IN	O
52 	52 	 CD	O
,  	,  	 ,	O
malignant  	malignant  	 JJ	O
pleurisy  	pleurisy  	 NN	O
in  	in  	 IN	O
39 	39 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
parapneumonic  	parapneumonic  	 JJ	B-NP
effusions  	effusions  	 NN	I-NP
in  	in  	 IN	O
29  	29  	 CD	O
patients 	patients 	 NNS	O
.  	.  	 .	O
We  	We  	 PRP	O
measured  	measured  	 VBD	B-NP
serum  	serum  	 CD	I-NP
IL-12p40  	IL-12p40  	 CD	I-NP
and  	and  	 CC	O
adenosine  	adenosine  	 JJ	B-NP
deaminase  	deaminase  	 NNS	I-NP
( 	( 	 -LRB-	O
ADA 	ADA 	 NNP	B-NP
)  	)  	 -RRB-	O
levels  	levels  	 NNS	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
tuberculous  	tuberculous  	 JJ	B-NP
pleurisy  	pleurisy  	 NN	I-NP
and  	and  	 CC	O
in  	in  	 IN	O
a  	a  	 DT	O
control  	control  	 NN	B-NP
group  	group  	 NN	I-NP
treated  	treated  	 VBN	O
for  	for  	 IN	O
pleural  	pleural  	 JJ	B-NP
effusion  	effusion  	 NN	I-NP
to  	to  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
such  	such  	 JJ	O
levels  	levels  	 NNS	O
were  	were  	 VBD	O
useful  	useful  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
diagnosis  	diagnosis  	 NN	O
of  	of  	 IN	O
pleural  	pleural  	 JJ	B-NP
effusion  	effusion  	 NNS	I-NP
( 	( 	 -LRB-	O
p  	p  	 FW	O
< 	< 	 SYM	O
0.005 	0.005 	 FW	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Definite  	Definite  	 JJ	B-NP
microbiological  	microbiological  	 NN	I-NP
or  	or  	 CC	O
histopathological  	histopathological  	 JJ	B-NP
diagnoses  	diagnoses  	 NN	I-NP
of  	of  	 IN	I-NP
tuberculous  	tuberculous  	 JJ	I-NP
pleurisy  	pleurisy  	 NN	I-NP
or  	or  	 CC	O
pleural  	pleural  	 JJ	B-NP
effusion  	effusion  	 NN	I-NP
were  	were  	 VBD	O
recorded 	recorded 	 VBN	O
,  	,  	 ,	O
and  	and  	 CC	O
we  	we  	 PRP	O
found  	found  	 VBD	O
that  	that  	 IN	O
ADA  	ADA  	 NNP	B-NP
and  	and  	 CC	O
serum  	serum  	 JJ	B-NP
soluble  	soluble  	 JJ	O
IL-2  	IL-2  	 CD	B-NP
receptor  	receptor  	 NN	I-NP
levels  	levels  	 NNS	I-NP
aided  	aided  	 VBN	O
in  	in  	 IN	O
diagnosis  	diagnosis  	 NN	O
( 	( 	 -LRB-	O
p  	p  	 FW	O
< 	< 	 SYM	O
0.001 	0.001 	 FW	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
ADA  	ADA  	 NNP	B-NP
and  	and  	 CC	O
soluble  	soluble  	 JJ	O
IL-2  	IL-2  	 NN	B-NP
in  	in  	 IN	O
pleural  	pleural  	 FW	B-NP
effusions  	effusions  	 FW	I-NP
afforded  	afforded  	 FW	O
sensitivities  	sensitivities  	 FW	O
and  	and  	 CC	O
specificities  	specificities  	 NN	O
of  	of  	 IN	O
84.62 	84.62 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
82.69 	82.69 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
of  	of  	 IN	O
70.59 	70.59 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
80.88 	80.88 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
soluble  	soluble  	 JJ	O
IL-2  	IL-2  	 CD	B-NP
receptor  	receptor  	 NN	I-NP
level  	level  	 NN	I-NP
afforded  	afforded  	 VBN	O
a  	a  	 DT	O
sensitivity  	sensitivity  	 NN	O
and  	and  	 CC	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
82.69 	82.69 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
52.9 	52.9 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
IL-12p40  	IL-12p40  	 NNP	B-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
pleural  	pleural  	 JJ	B-NP
effusions  	effusions  	 NN	I-NP
and  	and  	 CC	O
sera  	sera  	 JJ	B-NP
afforded  	afforded  	 JJ	O
sensitivities  	sensitivities  	 NNS	O
and  	and  	 CC	O
specificities  	specificities  	 NN	O
of  	of  	 IN	O
80.77 	80.77 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
80.77 	80.77 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
of  	of  	 IN	O
60.29 	60.29 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
39.71 	39.71 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Soluble  	Soluble  	 NNP	B-NP
IL-2  	IL-2  	 NNP	I-NP
receptor  	receptor  	 NN	I-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
tuberculous  	tuberculous  	 JJ	B-NP
pleurisy  	pleurisy  	 NNS	I-NP
serve  	serve  	 VBP	O
as  	as  	 RB	O
markers  	markers  	 VBN	O
of  	of  	 IN	O
disease  	disease  	 NN	O
in  	in  	 IN	O
non-endemic  	non-endemic  	 JJ	B-NP
countries 	countries 	 NNS	I-NP
,  	,  	 ,	O
similarly  	similarly  	 RB	O
to  	to  	 TO	O
ADA  	ADA  	 NNP	B-NP
levels 	levels 	 NNS	I-NP
.  	.  	 .	O
